RxDoctor Payments DataLook up a doctor →

Rachael Greer

Adult Health · Seaside, ORNPI 1043841265

Payments from drug & device makers

$6,720in general payments, 2019–2025

Across 395 payments — averaging $17.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$814
  • Merck$443
  • Incyte Corporation$441
  • Johnson & Johnson$356
  • Sanofi$342
  • AstraZeneca$340
  • plus $4K from 44 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis50$814
Merck26$443
Incyte Corporation30$441
Johnson & Johnson23$356
Sanofi17$342
AstraZeneca(2 entities)23$340
Genentech USA, Inc.16$272
Amgen15$253
Daiichi Sankyo Inc.11$227
Pfizer14$222
Lilly USA, LLC12$209
Deciphera Pharmaceuticals Inc.9$185
Bristol Myers Squibb10$168
Beigene USA, Inc.9$162
Astellas Pharma US Inc9$150
Seagen Inc.9$147
Bayer7$143
EMD Serono, Inc.9$141
Gilead(2 entities)7$118
Rigel Pharmaceuticals, Inc.7$118
AbbVie5$100
Eisai Inc.6$98
Takeda Pharmaceuticals U.S.A., Inc.5$94
E.r. Squibb & Sons, L.L.C.6$94
Ipsen Biopharmaceuticals, Inc4$88
Sobi, Inc4$83
Blueprint Medicines Corporation5$82
Puma Biotechnology, Inc.5$78
Pharmaessentia USA Corporation3$74
Karyopharm Therapeutics Inc.4$68
Pharmacyclics LLC, An Abbvie Company5$65
Morphosys, US Inc.2$60
Exelixis Inc.4$60
Regeneron Healthcare Solutions, Inc.2$49
AVEO Pharmaceuticals, Inc.2$45
Secura Bio, Inc.3$35
Jazz Pharmaceuticals Inc.2$35
Tersera Therapeutics LLC2$34
Boehringer Ingelheim2$29
Pharmacosmos Therapeutics Inc.1$27
Sanofi US Services Inc.1$23
Array Biopharma Inc1$20
ADC Therapeutics America, Inc.1$20
Servier Pharmaceuticals LLC1$19
Coherus Oncology, Inc.1$19
GSK1$15
G1 Therapeutics, Inc.1$14
Alnylam Pharmaceuticals Inc.1$14
Azurity Pharmaceuticals, Inc.1$14
Dova Pharmaceuticals1$13

How this compares

$6,720 in reported general payments places this provider in the 90th percentile of 96 adult health providers in Oregon.

See all adult health providers in Oregon →

Medicare billing

Part B allowed, 2024
$7,933
Medicare patients
70
Services billed
96

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other adult health in Seaside

See the full list for Oregon →

Where these figures come from

Is this you, or does something look wrong? →